BioHarvest Sciences Inc.
NGM: BHSTLive Quote
📈 ZcoreAI Score
Our AI model analyzes BioHarvest Sciences Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get BHST Z-Score →About BioHarvest Sciences Inc.
Consumer Defensive
Packaged Foods
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
📊 Fundamental Analysis
BioHarvest Sciences Inc. demonstrates a profit margin of -32.3%, which is below the sector average, suggesting competitive pressure.
The company recently reported 24.6% revenue growth, which is well above average for the Consumer Defensive sector.
Return on Equity (ROE) is -83.2%, which indicates that capital utilization is currently under pressure.
At a current price of $4.31, BHST currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $4.10 - $12.80).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$97.70M
Trailing P/E
--
Forward P/E
-107.75
Beta (5Y)
1.40
52W High
$12.80
52W Low
$4.10
Avg Volume
26K
Day High
Day Low